SCHEMBL6622210

SCHEMBL6622210

O=C(NCCO)c1ccc2c(c1)COC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.54
POLB P06746 2/20 0.54
HTT P42858 1/20 0.54
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 4/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
TP53 P04637 1/20 0.44
CASP1 P29466 1/20 0.44
NAMPT P43490 1/20 0.44
MMP13 P45452 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
ESR2 Q92731 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996878 0.76 RAB9A (0.44) HPGDPOLBHTTKDM4EALDH1A1
SCHEMBL16906829 0.76 CA1 (0.61) HPGDPOLBHTTCA12CA1
SCHEMBL16906828 0.76 PDE4B (0.49) HPGDPOLBHTTKDM4EALDH1A1
SCHEMBL620074 0.75 POLB (0.66) HPGDPOLBHTTKDM4EALDH1A1
SCHEMBL14590643 0.75 NAMPT (0.55) HPGDPOLBHTTNAMPT
SCHEMBL14211966 0.74 ALDH1A1 (0.44) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL14625864 0.74 NAMPT (0.54) HPGDPOLBHTTKDM4EALDH1A1
SCHEMBL3319225 0.72 SMN1; SMN2 (0.65) HPGDPOLBHTTKDM4EALDH1A1
SCHEMBL17327561 0.72 ALDH1A1 (0.62) HPGDPOLBKDM4EALDH1A1TP53
SCHEMBL29516904 0.72 ALDH1A1 (0.62) HPGDPOLBKDM4EALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458703-A1 ISOCHROMAN COMPOUNDS FOR TREATMENT OF CNS DISORDERS ELI LILLY AND COMPANY (US) 2004-09-22 EP disclosed
EP-1345930-A2 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 2003-09-24 EP disclosed
WO-2003053948-A1 ISOCHROMAN COMPOUNDS FOR TREATMENT OF CNS DISORDERS ELI LILLY AND COMPANY (US) 2003-07-03 WO disclosed
WO-2002050067-A2 PHARMACEUTICAL HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 2002-06-27 WO disclosed